Regulation of BAP1 activity by novel cancer-associated glutamate residues through ubiquitin binding and PARylation
Biochemical and Biophysical Research Communications · 2026
DOI: 10.1016/j.bbrc.2025.153166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Jiyeon Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Science, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, South Korea. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Tumor Suppressor Proteins, Glutamic Acid, Ubiquitin. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
BAP1 is a deubiquitinase with a ubiquitin C-terminal hydrolase domain that functions as a tumor suppressor and regulates key cellular processes, including DNA repair. Mutations in BAP1 are prevalent in cancers such as mesothelioma, uveal melanoma, and clear cell renal cell carcinoma, yet the functional consequences of individual residues remain incompletely defined. Here, using structural analysis, mutational screening, and cellular and in vitro assays, we identify three cancer-associated glutamate residues-Glu31, Glu200, and Glu201-that are also PARylation sites, as critical for BAP1's catalytic activity. Glu31 directly promotes ubiquitin binding through salt bridge formation with Arg72 of ubiquitin, whereas Glu200 and Glu201 contribute indirectly without direct ubiquitin engagement. Our data suggest that Glu200 and Glu201 help preserve the local structural environment-including the positioning of Glu31 through the β1-β2 loop-thereby supporting a conformation required for efficient catalysis. We further show that PARylation inhibits BAP1 activity, likely by disrupting these salt bridges, thereby providing a dynamic mode of enzymatic regulation. These findings define previously uncharacterized cancer-associated residues essential for BAP1 function, reveal a novel salt bridge-mediated mechanism that enhances ubiquitin binding, and suggest that PARylation serves as a regulatory switch for BAP1 activity with potential implications for tumorigenesis and therapeutic targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Science, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, South Korea.
- Department of Chemistry and Nanoscience, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, South Korea.
- Department of Life Science, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, South Korea. Electronic address: jongkwon@ewha.ac.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Lee, J., Kim, S., Lee, B., Lee, D., Youn, S. Y., Jung, M., Shim, H., Cha, S. S., & Kwon, J. (2026). Regulation of BAP1 activity by novel cancer-associated glutamate residues through ubiquitin binding and PARylation. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.153166
Vancouver
Lee J, Kim S, Lee B, Lee D, Youn SY, Jung M, et al. Regulation of BAP1 activity by novel cancer-associated glutamate residues through ubiquitin binding and PARylation. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2025.153166
BibTeX
@article{Lee2026,
author = {Lee, Jiyeon and Kim, Soyi and Lee, Boram and Lee, Daye and Youn, So-Yeon and Jung, Mooyoung and Shim, Hyunbo and Cha, Sun-Shin and Kwon, Jongbum},
title = {Regulation of BAP1 activity by novel cancer-associated glutamate residues through ubiquitin binding and PARylation},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
doi = {10.1016/j.bbrc.2025.153166}
}
EUVIMED